Background: Aortic valve replacement (AVR) improves left ventricular (LV) systolic function in patients with chronic aortic regurgitation (AR). The objective of this study is to determine predictors for normalization of impaired LV systolic function after valve replacement for chronic AR.
ortic regurgitation (AR) causes both volume overload and pressure overload. 1 As the disease progresses, preload reserve and compensatory hypertrophy permit the ventricle to maintain normal ejection performance with an increase in dimension and wall thickness despite the elevated afterload (called afterload mismatch). Most of these patients are asymptomatic and have an excellent prognosis. 2 In many patients, however, the balance between afterload excess, preload reserve, and hypertrophy cannot be maintained indefinitely; afterload mismatch, depressed contractility, or severe dilated left ventricular (LV) dimension ultimately results in reduced ejection fraction (EF). 2- 4 The standard of care is to monitor patients with chronic severe AR carefully and operate at the first sign of symptoms or LV dysfunction. 1,2,5 At this stage, surgical correction of AR can normalize or markedly improve LV systolic function.
Although the hemodynamic rationale for its correction can readily be appreciated in patients with a significantly dilated ventricle and impaired systolic function, surgery sometimes results in persistent LV dilatation and systolic dysfunction. 6- 9 The physiologic changes in the left ventricle after valve replacement are incompletely understood, 6 but the resulting systolic functional disturbances have important implications for morbidity and mortality before and after aortic valve replacement (AVR). 1,3, 10 In the present study, we assessed the postoperative course after AVR. We evaluated several predictors for early recovery of LV function following AVR in patients with isolated, severe AR combined with LV systolic dysfunction. Postoperative Recovery of LV Function in Chronic AR
Methods
From 1997 to 2007, 171 patients underwent primary isolated AVR for chronic AR (at least 6 months' duration) at the Severance Cardiovascular Center of Yonsei University Health System in Korea. Patients with acute AR such as aortic dissection and acute endocarditis, combined aortic stenosis, previous aortic valve surgery, concomitant coronary artery bypass graft, previous or associated mitral valve replacement or repair, and congenital disease unrelated to AR were excluded.
Of these 171 patients, the study group consisted of 79 patients with preoperative LV systolic dysfunction or severe LV dilatation, comprising 47% of our 171 experiences with AVR for chronic AR.
Preoperative LV systolic dysfunction was defined as EF <50%. Preoperative severe enlarged LV was defined as LV end-diastolic dimension (LVEDD) ≥70 mm and LV end-systolic dimension (LVESD) ≥50 mm. In 30 of the 79 patients, EF was 50-60% but LV dimension was severely enlarged, however, these patients were still included in this study.
Patients included 54 men (68%) and 25 women (32%) with a mean age of 49.0±14.8 years. The mean body surface area (BSA) was 1.69±0.20 m 2 . Twenty patients (25%) and 6 patients (8%) had class III and IV heart failure, respectively, according to the New York Heart Association (NYHA) functional classification system. The etiologies of AR were congenital anomaly in 20 patients, rheumatic AR in 16, degeneration in 15, annulo-aortic ectasia in 12, and old infective endocarditis in 11. Preoperative variables are shown in Table 1 .
All patients had been treated with angiotensin-converting enzyme (ACE) inhibitors and other medications for heart failure prior to the operation. Hypothermic cardiopulmonary bypass and intermittent antegrade direct cold blood cardioplegia were used routinely for the surgical procedure. Sixty-nine of the patients (87%) received mechanical valves; 70 (89%) patients had isolated AVR; and 9 (13%) patients underwent concomitant replacement of the ascending aorta ( Table 1) .
Echocardiography was performed within 1 month before surgery, during the immediate postoperative period (7 days after AVR), at early follow up (the mean and median of follow-up time are both 6 months), and at late follow-up appointments. Normalization of LV systolic function was defined as an EF >50%. Regular follow up was conducted at an outpatient clinic or by an annual telephone call; follow up was terminated at the end of 2007. The study was approved by the Institutional Review Board of Yonsei University College of Medicine.
Echocardiographic Chamber Quantification
An echocardiographic assessment was made by using commercially available equipment with tissue Doppler echocardiography according to a standard protocol. Interventricular septal wall thickness and posterior wall thickness, and LV internal dimension at both the end-diastole and end-systole were measured using 2D images from the parasternal longaxis acoustic window. LV end-diastolic volume (EDV) and end-systolic volume (ESV) were measured by the biplane method of disks using 2D images from the apical 4-and 2-chamber views. The EF was calculated by the equation: 100 × (EDV -ESV)/EDV. The left atrial (LA) diameter was measured at the end of ventricular systole from both the parasternal long-axis and the apical 4-chamber views.
Statistical Analyses
Continuous variables are expressed as mean ± standard deviation. Cumulative survival was estimated by the KaplanMeier method using the date of surgery and date of the most recent follow up. Differences in survival rates were determined by log-rank analysis. The paired t-test was used to compare 2 groups, while ANOVA was used to compare more than 2 groups. A multivariable analysis of independent factors was performed by using stepwise regression. For continuous variables, diagnostic cut-off values with the most favorable sensitivities and specificities were identified by receiveroperating characteristics curve analysis. Statistical significance was defined as a 2-tailed P-value <0.05. SPSS for Windows, Release 15.0 (SPSS Inc, Chicago, IL, USA) was used for statistical analysis.
Results
Among the 171 patients who underwent AVR at our hospital, operative mortality was 2.9% (5/171), and overall survival was 89.8%, whereas operative mortality of the 79 patients in the present study was 3.7% (3/79), and overall survival was 86.9%. However, there was no significant difference in overall survival (operative and late deaths combined) between the 79 patients of our study group and the patients with preserved LV function and LV dimension (Figure 1) . In a multivariate analysis using the Cox regression model, no variables were found to be independent predictors of operative mortality and overall survival. Table 2 shows the variables before and after the operation. Before the procedure, the mean preoperative EF was 49± 10%, the mean LVESD was 52.32±8.35 mm, and the mean LVEDD was 69.59±7.80 mm. In the immediate postoperative period, the mean EF and LV dimensions were decreased. An early postoperative follow-up echocardiography (median, 6 months; mean, 6.43±2.03 months) showed that the mean EF increased from 49 to 55%. Both LVESD and LVEDD were significantly decreased after AVR (52.32±8.35 mm vs 37.82±6.88 mm, 69.59±7.80 mm vs 51.55±6.40 mm, respectively). At all time-points, the mean EFs and LV dimensions were significantly different, according to analysis of variance (ANOVA) and Tukey's multiple comparison test. Sixty-two of the 79 patients (78%) achieved normal LV systolic function in the early postoperative period. A late follow-up echocardiography (median, 35 months; mean 45 months; range, 12 months to 10 years) showed that LV systolic function was not restored in 7 of the remaining 17 patients (41%).
Univariate risk analysis demonstrated that NYHA functional classes, preoperative EF, LV dimensions, indexed LV dimensions, and LA volume index were significant risk factors for early recovery of LV function after AVR. The immediate postoperative change in LVEF was not predictive of normal EF during the early preoperative period; however, multivariate stepwise regression analysis showed that preoperative indexed LVESD and preoperative indexed LVEDD were significant predictors (odds ratios [OR], 7.60 and 0.383, respectively) ( Table 3) . Using receiver-operating characteristics curves, we found that the sensitivity and specificity for predicting the normalization of EF early after AVR were 86% and 71% for indexed LVEDD (<44.42 mm/m 2 ), 68% and 91% for indexed LVESD (<35.32 mm/m 2 ) (Figure 2) . In other words, patients with an indexed LVEDD >44.42 mm/m 2 and an indexed LVESD >35.32 mm/m 2 had only a 29% and 9% chance of LVEF normalization after AVR, respectively.
Discussion
In patients with severe chronic AR, the presence of symptoms is considered a class I indication for AVR. In asymptomatic patients, surgery is recommended when LV dysfunc- 11 This effect is more pronounced in patients with a low body surface area. Actually, Asian hearts are small compared with the reference values in the guidelines from the American Society of Echocardiography and BSA is also significantly low. 13 Other investigators showed that larger indexed LV dimensions were associated with late mortality, indicating the importance of indexed values. 12 In the present study, we therefore assessed the postoperative course of patients with isolated, severe AR combined with LV systolic dysfunction. We also evaluated several predictors containing indexed values of echocardiographic parameters following AVR.
Mortality and Late Survival
Earlier studies showed that patients with markedly low EF (<35%) or dilated LV constitute a high-risk group even after successful surgery. with LV dysfunction. Regarding overall survival (operative and late deaths combined), there was no significant difference between the 79 patients of our study group and patients with preserved LV function and LV dimension. We were unable to identify predictors for mortality and late survival. Brown et al showed that decreased LVEF and increased LV dimensions were not associated with late mortality, but that larger indexed LV systolic and diastolic dimensions predicted late mortality. 12 Klodas et al showed that extreme LV dilatation was not predictive of mortality and overall survival, and that preoperative low EF was an independent predictor of survival. 9
Improvement in LV Systolic Function After AVR Enlarged LV dimension is usually reduced within the first few weeks after correction of AR, but EF also decreases at approximately the same time because the effect of preload change is likely to be dominant at this time. 
Clinical Implication
In chronic isolated AR, AVR should ideally be performed before severe EF decrease and LV dilatation. Previous studies demonstrated that persistent ventricular dilatation and dysfunction identifies patients at risk of death from congestive heart failure. 17, 19 Recently, operative mortality and overall survival was shown to decline after AVR in a high-risk group. Therefore, we prefer surgical correction over medically conservative care even in high-risk patients. On the basis of our findings and those of other investigators, early surgical treatment might be important for postoperative clinical outcomes even in patients with severe LV dilatation and LV dysfunction, considered with reference to indexed LV dimensions. In the present study, the cut-off values for indexed LV dimensions were not indicators of surgical correction, but indicated the upper limit for delaying AVR.
Study Limitations
There are several limitations in this study. First, this study is a retrospective study. In addition, we did not evaluate preoperative predictors for mid-term or long-term LV function because mid-term or late follow-up echocardiograms were obtained in only 50 of the 79 patients. However, previous studies demonstrated that early postoperative recovery of LV function was independently associated with long-term outcome and relief of symptoms. Second, postoperative NYHA functional class changes were not available for all patients; therefore, we were unable to determine the relationship between recovery of LV function and improvement of heart failure symptoms. Finally, our study group was made up of patients with LV dysfunction. Preoperative LV systolic dysfunction is generally defined as EF <50%; however, in the present study, EF was 50-60% in 30 of the 79 patients, but LV dimension was enlarged and global LV hypokinesia was detected by echocardiography. In AR, an abnormally increased preload by large regurgitant volume and an altered afterload might result in a overestimated EF despite underlying myocardial dysfunction (the likelihood of a decrease of 10-20%). 15 
Conclusion
In patients who received a valve replacement for chronic AR, decreased LVEF and large LV dimensions might not affect survival. However, smaller indexed LV systolic and diastolic dimensions and preoperative preserved EF were associated with early restoration of LV function after AVR. Thus, an indexed LV dimension evaluated along with symptoms and LVEF might help predict the postoperative clinical course and prognosis for patients with chronic AR.
